Trump Administration to End Medicare Drug Subsidy Program, Raising Concerns for Seniors

The Trump administration is ending a Medicare drug subsidy program, a decision that could impact prescription drug costs for 25 million seniors. While federal officials claim the financial impact will be minimal, Senate Minority Leader Chuck Schumer criticized the move, stating it actively raises prescription drug costs for older adults.